Skip to main content

Month: May 2023

Malaga Financial Corporation Announces 76th Consecutive Quarterly Cash Dividend

PALOS VERDES ESTATES, Calif., May 26, 2023 (GLOBE NEWSWIRE) — Malaga Financial Corporation (OTCPink:MLGF) announced today the declaration of a cash dividend in the amount of 25 cents per share to shareholders of record on June 23, 2023. This dividend represents a 4.35% annualized yield based on our most recent closing price of $23.00. The dividend will be paid out on or about July 3, 2023. Randy C. Bowers, Chairman, President and CEO, remarked, “In spite of recent turmoil in the economy and banking industry, we are pleased that our continued strong earnings and the strength of our balance sheet position us to declare this 25-cent quarterly dividend. We appreciate the efforts of our colleagues and the opportunity to continue to reward our shareholders for their investment.” Malaga Bank, a subsidiary of Malaga Financial Corporation,...

Continue reading

COMPASS Pathways to participate in upcoming Jefferies Healthcare Conference

LONDON, May 26, 2023 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the Jefferies Healthcare Conference at 3:30 pm ET on June 8, 2023. A live audio webcast of the presentation will be accessible from the “Events” page of the Investors section of the COMPASS website. The replay of the webcast will be accessible for 30 days following the event. For more information, please visit ir.compasspathways.com. About COMPASS Pathways COMPASS Pathways plc (Nasdaq: CMPS) is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health...

Continue reading

Results of the votes of the Combined Shareholders’ General Meeting of May 25, 2023

  Daix (France), Long Island City (New York, United States), May 26, 2023 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases with unmet medical need, today announced the results of the votes of its Combined Shareholders’ Meeting.  The Combined Shareholders’ Meeting was held on Thursday May 25, 2023 at 2 p.m. at Hôtel Oceania Le Jura, 14 avenue Foch, 21000 Dijon (France), under the chairmanship of Mr. Frédéric Cren, Chairman and Chief Executive Officer and cofounder of Inventiva. Mr. Frederic Cren proceeded to the usual formalities of the opening of the meeting, in particular to the constitution of the Bureau by appointing Mrs. Christelle Herbin and Mr. Jean...

Continue reading

OptimumBank Holdings, Inc. (OPHC-NASDAQ) Announces First Quarter Earnings

Fort Lauderdale, FL, May 26, 2023 (GLOBE NEWSWIRE) — OptimumBank Holdings, Inc. (NASDAQ: OPHC) and subsidiary OptimumBank today announced the company’s total assets increased by approximately $37 million to $622 million as of March 31, 2023, from $585 million at December 31, 2022, primarily due to increases in loans, and cash and cash equivalents. The growth in assets was attributable to the success of the Company’s efforts to increase loans and deposits from new customers. Net loans grew by $18 million. Deposits grew by approximately $19 million to $527 million as of March 31, 2023 from $508 million at December 31, 2022. The Company increased the Federal Home Loan Bank advances by $15 million to $25 million as of March 31, 2023. Total stockholders’ equity increased by approximately $2 million to $65 million at March 31, 2023,...

Continue reading

Tofutti Brands Inc. Announces Receipt of Notification From the OTC Markets Group That It No Longer Meets the Standards for Continued Qualification

Cranford, New Jersey, May 26, 2023 (GLOBE NEWSWIRE) — TOFUTTI BRANDS INC. (OTCQX: TOFB) (“Tofutti” or the “Company”) today announced that on May 22, 2023 it received a notice from the OTC Markets Group indicating that the Company no longer meets the Standards for Continued Qualification for the OTCQX U.S. tier as per the OTCX Rules for U.S. Companies (Version 8.6) section 3.2.b.2. Specifically, the Company’s market capitalization has stayed below $5 million for the past 30 consecutive calendar days. The Company has a cure period of 180 calendar days, expiring November 20, 2023, to regain compliance. In order to regain compliance, the Company’s market capitalization must stay at or above $5 million for 10 consecutive trading days within the cure period. The Company may also seek a transfer to the OTCQB market. About Tofutti Brands...

Continue reading

Biodexa Pharmaceuticals PLC Announces Closing of $3.32 Million Registered Direct Offering

26 May 2023 Biodexa Pharmaceuticals PLC Announces Closing of $3.32 Million Registered Direct Offering               Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (NASDAQ: BDRX), a clinical stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain, today announced the closing of its previously announced registered direct offering (the “Registered Direct Offering”) of 22,135,922 new American Depositary Shares (“the Registered ADSs”) at a price of US$0.15 (equivalent to approximately US$0.03 per ordinary share).                The net proceeds to Biodexa from the Registered Direct Offering were approximately US$2.61 million (£2.11 million), after deducting the placement agent’s fees and other estimated expenses. The Company intends to use the proceeds for working capital...

Continue reading

Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin) for Treatment of Heart Failure

INPEFA granted broad label across full range of left ventricular ejection fraction, including HFpEF and HFrEF, and for patients with or without diabetes INPEFA reduced the risk of total occurrence of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits by 33% compared to placebo in the SOLOIST-WHF study Conference Call and Webcast on Tuesday, May 30, 2023, at 8:00 am Eastern Time THE WOODLANDS, Texas, May 26, 2023 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the U.S. Food and Drug Administration (FDA) has approved INPEFA™ (sotagliflozin), a once-daily oral tablet to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with:heart failure or type 2 diabetes mellitus, chronic kidney disease,...

Continue reading

Robinhood Markets, Inc. to Present at the Bernstein Strategic Decisions Conference on June 2, 2023

MENLO PARK, Calif., May 26, 2023 (GLOBE NEWSWIRE) — Today, Robinhood Markets, Inc. (NASDAQ: HOOD) announced that it will be participating in the upcoming Bernstein Strategic Decisions Conference on June 2, 2023. Robinhood CEO and Co-Founder Vlad Tenev is scheduled to present on Friday, June 2, 2023 at 11:00 AM ET / 8:00 AM PT. Interested parties may access a live audio webcast of the presentation by visiting the “Events” section of the company’s investor relations website at investors.robinhood.com. Following the presentation, a recording will be available for replay for at least 90 days on the same website. About Robinhood Robinhood Markets is on a mission to democratize finance for all. With Robinhood, people can invest with no account minimums through Robinhood Financial LLC, buy and sell crypto through Robinhood Crypto, LLC,...

Continue reading

Genesis Growth Tech Acquisition Corp. Receives Notice from Nasdaq Regarding Delayed Quarterly Report

NIDWALDEN, Switzerland, May 26, 2023 (GLOBE NEWSWIRE) — Genesis Growth Tech Acquisition Corp. (Nasdaq: GGAA) (“GGAA” or “Genesis”), announced today that it had received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating GGAA was not in compliance with Nasdaq Listing Rule 5250(c)(1), as a result of not having timely filed its Quarterly Report on Form 10-Q for the period ended March 31, 2023 and for remaining delinquent in filing its Annual Report on Form 10-K for the year ended December 31, 2022. The Nasdaq notification letter has no immediate effect on the listing of the Company’s units, common stock or warrants on The Nasdaq Global Market. The Nasdaq notification letter provides the Company until June 20, 2023, to submit a plan to Nasdaq to regain compliance with...

Continue reading

Dynamic Technologies Announces Termination of Sales and Investment Solicitation Process and Extension of Stay

WINNIPEG, Manitoba, May 26, 2023 (GLOBE NEWSWIRE) — Dynamic Technologies Group Inc. (NEX: DTG.H, OTC:ERILF) (“Dynamic” or “Company”) announces that, further to the previously announced sales and investment solicitation process (the “SISP”) under the Companies’ Creditors Arrangement Act (the “CCAA”), on May 9, 2023, FTI Consulting Canada Inc., the court-appointed monitor (the “Monitor”) terminated the SISP to enable Dynamic and its subsidiaries, Dynamic Attractions Ltd., Dynamic Entertainment Group Ltd., Dynamic Structures Ltd. and Dynamic Attractions Inc. (collectively, the “Subsidiaries”) to finalize the definitive agreements for the sale transaction (the “Sale Transaction”) contemplated by the high value letter of intent provided by Promising Expert Limited. The closing of the proposed Sale Transaction is subject to certain standard...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.